Leptin, the o b gene product that can decrease caloric intake and increase energy expenditure, is functionally released by insulin from adipose tissue. Adenosine is thought to be an important regulator of the action of insulin in adipose tissue. The present study investigated the role of adenosine in the release of leptin by insulin in isolated rat white adipocytes. Release of leptin, measured by radioimmunoassay, from insulin-stimulated samples was seen after 30 min. Adenosine deaminase, at concentrations sufficient to metabolize endogenous adenosine, decreased insulin-stimulated leptin release. Also, the insulin-stimulated leptin release was completely blocked by the adenosine A 1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX). Mediation of endogenous adenosine in this action of insulin was further supported by the assay of adenosine released into the medium from adipocytes stimulated with insulin. In addition, activation of adenosine A 1 receptors by N 6 -c y c l o p e n t y l a d e n o s i n e ( C PA) induced an increase in leptin release in a concentration-dependent manner that could be blocked by antagonists, either DPCPX or 8-(p-s u l f o p h e n y l ) t h e ophylline (8-SPT). In the presence of U73312, a specific inhibitor of phospholipase C (PLC), CPA -s t i m u l a t e d leptin secretion from adipocytes was reduced in a concentration-dependent manner, but it was not affected by U73343, the negative control for U73312. Moreover, chelerythrine and GF 109203X diminished the CPAstimulated leptin secretion at concentrations suff i c i e n t to inhibit protein kinase C (PKC). These results suggest that, in isolated white adipocytes, the released adenosine acts as a helper and/or a positive regulator for insulin in the release of leptin via an activation of adenosine A 1 receptors that involves the PLC-PKC p a t h w a y. Diabetes 4 9 :2 0-24, 2000 T he o b gene, which encodes a 167-amino acid peptide named leptin in white adipocytes (1), has received increasing attention for its role in the regulation of food intake and whole-body energy balance in rodents and humans (2,3). It has been demonstrated that circulatory leptin levels in rats were modulated by exogenous insulin (4) and o b gene expression was induced by corticosteroids (5). Insulin also stimulated the mRNA levels of the o b gene in rat adipocytes (6). Thus, insulin appears to be one of the important regulators of o b gene expression and leptin secretion in adipose tissue.
T
he o b gene, which encodes a 167-amino acid peptide named leptin in white adipocytes (1) , has received increasing attention for its role in the regulation of food intake and whole-body energy balance in rodents and humans (2, 3) . It has been demonstrated that circulatory leptin levels in rats were modulated by exogenous insulin (4) and o b gene expression was induced by corticosteroids (5) . Insulin also stimulated the mRNA levels of the o b gene in rat adipocytes (6) . Thus, insulin appears to be one of the important regulators of o b gene expression and leptin secretion in adipose tissue.
Adenosine is another endogenous regulator in adipose tissue. Under physiological concentrations, adenosine increased the sensitivity of glucose transport (7, 8) and glucose oxidation and/or metabolism (9, 10) to the stimulation with insulin in adipocytes. Also, the action of adenosine in adipose tissue appears to be mainly through activation of adenosine A 1 receptors (10, 11) . The release of adenosine from adipose tissue has also been demonstrated (12, 13) . However, the role of adenosine in mediating the effect of insulin on leptin release is still unknown. Thus, in the present study, we examined the release of adenosine in response to insulin at concentrations sufficient to stimulate release of leptin from rat white adipocytes, and we studied the role of adenosine A 1 receptors using specific agonists and antagonists. -cyclopentyladenosine (CPA) (Research Biochemical) at the desired concentrations for another 30 min to stimulate the release. The medium from each incubation was then collected and frozen at -70°C until the assay for leptin or adenosine was performed. Leptin analysis. Leptin secreted into the incubation medium was determined by radioimmunoassay using a commercially available kit (Linco Research, St. Charles, MO), as described previously (15). The sensitivity of the assay was 0 . 2 ng/ml. Samples from an individual were analyzed in triplicate at the same time.
The obtained values were indicated as nanograms of leptin-like immunoreactivity per milliliter of plasma. Insulin or other test compounds used in the present study did not affect the binding of leptin with antibodies. Adenosine analysis. The amount of adenosine in the medium was measured by high-performance liquid chromatography with fluorescence detection, as previously described (16). The wavelengths for excitation and emission were set at 305 and 420 nm, respectively. The mobile phase, 5 mmol/l citrate buffer with 1.5% acetonitrile, was adjusted to pH 4.5 with 2-diethylaminoethanol and was run at a flo w rate of 1.0 ml/min at ambient temperature (22-24°C). The concentration of adenosine was calibrated from the standards, as described previously (16). Statistics. Results are expressed as means ± SE from each group, and the number (n) of rats is indicated. Data for concentrations of adenosine or leptin were analyzed using one-way analysis of variance. P values ≤0.05 were regarded as signific a n t .
R E S U LT S
E ffect of insulin on leptin release from the isolated white adipocytes. The amount of leptin accumulated in the medium from adipocytes stimulated with insulin was determined. In the preliminary study, the effective concentration of insulin (35 nmol/l) for induction of leptin secretion was obtained and used in subsequent studies. As shown in Ta b l e 1, incubation of freshly isolated rat adipocytes with insulin produced a marked release of leptin into the incubation medium. Under stimulation with insulin, the maximal release of leptin was evident after 30 min. A 30-min preincubation of adipocytes with ADA, which can decrease endogenous adenosine by converting it to inosine, caused a concentration-related inhibition of insulin-stimulated leptin release (Ta b l e 1). However, incubation with ADA produced a nonsignificant reduction in the spontaneous secretion of leptin (P > 0.05).
M o r e o v e r, as shown in Ta b l e 1, preincubating adipocytes with an antagonist of adenosine A 1 receptors, DPCPX, for 30 min also caused a concentration-related inhibition of insulinstimulated leptin secretion. Similarly, the basal secretion of leptin was not significantly modified by DPCPX. E ffect of insulin on adenosine release from isolated white adipocytes. Adenosine was determined in the medium containing adipocytes incubated with insulin at desired concentrations for 30 min. As shown in Fig. 1 , insulin enhanced adenosine release from isolated adipocytes in a concentration-dependent manner (n = 8). E ffect of CPA on leptin secretion from isolated white adipocytes. To examine the role of adenosine A 1 r e c e p t o r s in leptin secretion from isolated adipocytes, an agonist of adenosine A 1 receptors, CPA, was used. After a 30-min incubation of isolated adipocytes with CPA, a concentrationdependent increase of leptin release was seen in samples treated with CPA at concentrations from 0.1 to 10 µmol/l ( F i g . 2). To further examine whether these effects of the adenosine analog were mediated through adenosine receptors, the selective adenosine antagonists DPCPX and 8-SPT were added into the incubation medium. The basal secretion of leptin was not significantly modified by DPCPX and 8-S P T, but a concentration-dependent blockade of CPA -s t i m u l a t e d leptin release was observed in adipocytes receiving a 30-min preincubation with DPCPX at concentrations from 0.01 to 1 µmol/l (Ta b l e 2). Similar antagonism by 8-SPT to the action of CPA was also obtained (Ta b l e 2). Moreover, the action of C PA was enhanced by insulin. Coincubation of insulin ( 7 nmol/l) and CPA (0.1 µmol/l) induced the release of l e p t i n to 1.48 ± 0.14 ng/ml (n = 6), which was significantly different (P < 0.05) from that of the insulin (7 nmol/l) alone-s t i m u l a t e d group (1.16 ± 0.10 ng/ml; n = 6) or the CPA (0.1 µ m o l / l ) -induced release (1.01 ± 0.09 ng/ml; n = 6). E ffects of inhibitors of phospholipase C or protein kinase C on leptin secretion from isolated white a d i p o c y t e s . In the present study, U73122 was used to inhibit phospholipase C (PLC) activity and U73343 was used as the negative control. After a 30-min preincubation with U73122 or U73343, adipocytes were treated with 10 µmol/l CPA for another 30 min. As shown in Ta b l e 3, CPA-stimulated leptin secretion was decreased by U73122 in a concentrationdependent manner (n = 6). Addition of the inactive congener U73343 failed to modify the action of CPA (P > 0.05), even at 3.3 µmol/l, which was the maximal concentration of U73122 used to abolish the action of CPA totally (Ta b l e 3). However, neither U73122 nor U73343 significantly modified the basal secretion of leptin from adipocytes. M o r e o v e r, chelerythrine and GF 109203X were used to inhibit the action of protein kinase C (PKC). After preincubation with chelerythrine or GF 109203X at the indicated concentrations for 30 min, adipocytes were incubated with C PA at 10 µmol/l for another 30 min. As shown in Ta b l e 4, both chelerythrine and GF 109203X decreased the CPA -s t i m u l a t e d leptin release from isolated white adipocytes in a concentration-dependent manner (n = 6). Similarly, the basal secretion of leptin was not significantly (P > 0.05) modified by either of these inhibitors.
D I S C U S S I O N
In the present study, we found that adenosine appears to be involved in the insulin-stimulated release of leptin from isolated rat adipocytes. In addition to the regulation of leptin gene expression by insulin (1), it has also been shown previously that insulin produces a rapid and marked release of leptin from freshly isolated rat adipocytes (15). A similar release of leptin by insulin was observed in the present study. Howe v e r, mediation of this insulin action by endogenous adenosine has not been reported before.
Adenosine has an ability to mimic insulin action in tissues, especially the adipose tissue, where the effects of insulin are m o d i fied by changes in adenosine levels, including the effects on glucose transport (7, 8) , glucose oxidation (9,10), lipolysis (10, 11) , and the activity of cAMP phosphodiesterase (17) or pyruvate dehydrogenase (18). Therefore, changes in adenosine levels and/or stimulation of adenosine receptors may influence the function of insulin in both responsiveness and sensitivity. The present study supports this view from the findings that ADA at concentrations sufficient to convert endogenous adenosine to inosine (10, 19) reduced the stimulation of insulin on leptin secretion from freshly isolated rat adipocytes (Ta b l e 1). Actually, insulin caused a concentrationdependent release of adenosine from rat white adipocytes ( F i g . 1). Mediation of adenosine in insulin-stimulated leptin release from adipocytes can thus be considered. However, the amount of adenosine in the present study was not at the absolute level that needs to be estimated in the future. An important role of adenosine A 1 receptors in rat adipocytes has been documented (20). The antagonists spec i fic for the adenosine A 1 r e c e p t o r, either DPCPX (21) or 8-SPT (22), were thus used to study the role of adenosine A 1 receptors in insulin-stimulated leptin release. The stimulatory effect of insulin on leptin secretion was blocked by DPCPX in a concentration-dependent manner (Ta b l e 1). The mechanism would therefore appear to involve activation of adenosine A 1 receptors. Moreover, pharmacological manipulation with CPA to activate adenosine A 1 receptors also enhanced leptin secretion into the medium in a concentration-related manner (Fig. 2) . The stimulatory effect of CPA on leptin release was reversed by the preincubation of adipocytes with DPCPX or 8-SPT at concentrations sufficient to block adenosine A 1 receptors. Moreover, the action of CPA was facilitated by coincubation with insulin. This further indicates that the amount of adenosine released by insulin is sufficient to mimic the CPA-stimulated leptin secretion by activation of adenosine A 1 receptors in isolated adipocytes. However, the release of leptin by insulin was reduced but not abolished by ADA or DPCPX (Ta b l e 1). Also, the basal secretion of leptin was not significantly affected by blockade of adenosine A 1 receptors or ADA (Ta b l e 1). Therefore, the mediation of insulin-stimulated leptin secretion by adenosine seems to be only partial and not complete. A similar response in physiological function can thus be considered.
The accumulation of diacylglycerol and Ca 2 + as a result of activation of PLC causes the activation of PKC (23). Activation of adenosine A 1 receptors may link to this subcellular signaling (24).We found that PLC-PKC may be a major signaling pathway of adenosine A 1 receptors in CPA-stimulated leptin release using inhibitors specific for PLC or PKC. Recently, U73122 has been widely used as a specific inhibitor of PLC (25), and U73122 has been used as the negative control for U73343 (26). Preincubation with U73122 abolished the CPAstimulated leptin secretion from isolated white adipocytes, indicating the participation of PLC. Also, U73343, the negative control of U73122, failed to modify this stimulatory action of CPA (Ta b l e 3). This indicates that PLC mediates in the stimulation of leptin secretion by adenosine A 1 r e c e p t o r s in isolated white adipocytes. Direct determination of the PLC activity in adipocytes treated with CPA will provide helpful evidence of this view.
The role of PKC was investigated using chelerythrine (27) and GF 109203X (28), both of which can inhibit PKC in a competitive manner with respect to the phosphate acceptor. In the presence of either of these PKC inhibitors, the release of leptin induced by CPA from isolated adipocytes was attenuated in a concentration-dependent manner (Ta b l e 4). Although we did not determine the activity of PKC directly, chelerythrine or GF 109203X inhibited the action of CPA at concentrations that would be sufficient to inhibit PKC activity (27,28). Mediation of PKC in the action of CPA can thus be considered. Taken together, the involvement of the PLC-PKC pathway in the stimulation of leptin secretion by an activation of adenosine A 1 receptors can thus be considered. Currently, phosphatidylinositol 3-kinase and Map/Erk kinase are reported to have a key role in insulin-stimulated leptin synthesis and secretion in rat adipocytes (29). The relationship of this signal to the PLC-PKC pathway should be clarifie d using molecular tools or other methods in the future.
In conclusion, the present study shows that insulin may increase the secretion of adenosine from adipocytes. An activation of adenosine A 1 receptors through the PLC-PKC pathway may increase the insulin-stimulated release of leptin in isolated white adipocytes.
